The present invention relates to the enhydrous or hydrate forms of en-(3-ethynylphenyl)-6,7-bis (2-methoxyethoxy)-4-quinazoline amine mesylate. The present invention also relates to pharmacological compounds comprising en-(3-ethynylphenyl)-6,7-bis (2-methoxyethoxy)-4-quinazoline amine mesylate, Ethynylphenyl)-6,7-bis (2-methoxyethoxy)-4-quinazolineamine mesylate to treat hyperproliferative disorders such as cancer.
展开▼